Dipeptidyl peptidase IV in cell proliferation and differentiation
Sedo, A.; Kraml, J.
Sbornik Lekarsky 95(4): 285-288
1994
ISSN/ISBN: 0036-5327 PMID: 8867699 Document Number: 426037
In this short review we discuss the present knowledge of a dipeptidyl peptidase IV (DPP-IV, EC 3.4.14.5) physiological role, paying special attention to its involvement in complex processes of the cell cycle. Our own results and recent experimental project are overviewed in this respect too.
Document emailed within 1 workday
Related Documents
Sedo, A.; Malík, R.; Drbal, K.; Lisá, V.; Vlasicová, K.; Mares, V. 2001: Dipeptidyl peptidase IV in two human glioma cell lines European Journal of Histochemistry: Ejh 45(1): 57-63Kandeel, M.; Elaiziz, M.A.; Kandeel, A.; Altaher, A.A.; Kitade, Y. 2014: Association of host tropism of Middle East syndrome coronavirus with the amino acid structure of host cell receptor dipeptidyl peptidase 4 Acta Virologica 58(4): 359-363
Küllertz, G.; Fischer, G.; Barth, A. 1978: Catalytic mechanism of dipeptidyl-peptidase IV Acta Biologica et Medica Germanica 37(4): 559-567
Küllertz, G.; Barth, A.; Fischer, G. 1986: Determination of dipeptidyl-peptidase IV in biological materials Journal of Clinical Chemistry and Clinical Biochemistry 24(8): 551-558
Sanda, M.G.; Pierson, R.; Smith, C.; Reemtsma, K.; Rose, E. 1989: Serum dipeptidyl peptidase IV in cardiac transplant recipients Transplantation Proceedings 21(1 Part 3): 2525-2526
Heymann, E.; Mentlein, R.; Nausch, I.; Erlanson-Albertsson, C.; Yoshimoto, T.; Feller, A.C. 1986: Processing of pro-colipase and trypsinogen by pancreatic dipeptidyl peptidase IV Biomedica Biochimica Acta 45(5): 575-584
Giannoukakis, N. 2007: BIM-51077, a dipeptidyl peptidase-IV-resistant glucagon-like peptide-1 analog Current Opinion in Investigational Drugs 8(10): 842-848
Komatsu, M.; Urade, M.; Yamaoka, M.; Fukasawa, K.; Harada, M. 1987: Alteration in dipeptidyl peptidase activities in cultured human carcinoma cells Journal of the National Cancer Institute 78(5): 863-868
Krepela, E.; Kraml, J.; Vicar, J.; Kadlecová, L.; Kasafírek, E. 1983: Demonstration of two molecular forms of dipeptidyl peptidase IV in normal human serum Physiologia Bohemoslovaca 32(6): 486-496
Natori, Y.; Hayakawa, I.; Shibata, S. 1987: Identification of gp108, a pathogenic antigen of passive Heymann nephritis, as dipeptidyl peptidase IV Clinical and Experimental Immunology 70(2): 434-439
Wang, S.-C.; Zeng, L.-L.; Ding, Y.-Y.; Zeng, S.-G.; Song, H.-R.; Hu, W.-H.; Xie, H. 2014: A novel dipeptidyl peptidase IV inhibitors developed through scaffold hopping and drug splicing strategy Yao Xue Xue Bao 49(1): 61-67
Kalra, S. 2011: Emerging role of dipeptidyl peptidase-IV (DPP-4) inhibitor vildagliptin in the management of type 2 diabetes Journal of the Association of Physicians of India 59: 237-245
Mest, H.-J. 2006: Dipeptidyl peptidase-IV inhibitors can restore glucose homeostasis in type 2 diabetics via incretin enhancement Current Opinion in Investigational Drugs 7(4): 338-343
Simaga, S.; Babić, D.; Osmak, M.; Sprem, M.; Abramić, M. 2003: Tumor cytosol dipeptidyl peptidase III activity is increased with histological aggressiveness of ovarian primary carcinomas Gynecologic Oncology 91(1): 194-200
Dos Reis, G.A.; Shevach, E.M. 1982: Effect of cyclosporin a on T cell function in vitro: the mechanism of suppression of T cell proliferation depends on the nature of the T cell stimulus as well as the differentiation state of the responding T cell Journal of Immunology 129(6): 2360-2367
Harland, C.; Shah, T.; Webster, A.D.; Peters, T.J. 1988: Dipeptidyl peptidase IV--subcellular localization, activity and kinetics in lymphocytes from control subjects, immunodeficient patients and cord blood Clinical and Experimental Immunology 74(2): 201-205
Cuchacovich, M.; Gatica, H.; Pizzo, S.V.; Gonzalez-Gronow, M. 2001: Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases Clinical and Experimental Rheumatology 19(6): 673-680
Xu, J. 2004: Metabolic Diseases Drug Discovery-Strategic Research Institute's Third International World Summit. Dipeptidyl peptidase-IV inhibitors 26-27 July 2004, San Diego, CA, USA IDrugs: the investigational drugs journal 7(9): 839-840
Ellingsen, T.; Hansen, I.; Thorsen, J.; Kuno Møller, B.; Tarp, U.; Jacobsen, S.; Lund Hetland, M.; Vestergaard, A.; Hørslev-Petersen, K.; Stengaard-Pedersen, K. 2012: Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritis Clinical and Experimental Rheumatology 30(1): 58-63
Chen, L.; Mai, X.; Zha, L.G.H.; Wang, Y.; Chen, X. 2009: Effects of fibrin gels on cell proliferation and differentiation in MC3T3E1 cell line Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 23(7): 840-844